Project Details
Description
A Phase 2 Trial of Single-Agent Amrubicin in Patients with Extensive Disease Small Cell Lung Cancer that is Refractory or Progressive...
| Status | Finished |
|---|---|
| Effective start/end date | 8/26/06 → 12/31/10 |
Funding
- CABRELLIS PHARM CORP
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.